Therefore, this study aims to shed the first light on the impact of NRF2 genetic polymorphisms in HBV-related HCC risk, as well as the association with chronic hepatitis B (CHB) and HBV-related liver cirrhosis (LC). Here, NFE2L2 is linked to laryngotracheoesophageal cleft.